Who owns Autolus Therapeutics Plc spon ads?

Tip: Access positions for across all investors

Analyze quarterly positions in Autolus Therapeutics Plc spon ads with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Autolus Therapeutics Plc spon ads stock

Who bought or sold Autolus Therapeutics Plc spon ads this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of
Capital World Investors 3.0M $17M 0% Mar 2021
Capital Research and Management Company - Division 3 2.3M $13M 86% Mar 2021
Opaleye Management 2.1M $12M 100% Mar 2021
FMR 2.1M $12M 1736% Mar 2021
Schroder Investment Management Group 1.7M $9.6M 0% Mar 2021
Ikarian Capital 1.3M $7.2M 100% Mar 2021
Jpmorgan Chase & Co 554k $3.2M 118% Mar 2021
Sabby Management 525k $3.0M 100% Mar 2021
Granahan Investment Management 341k $2.0M -27% Mar 2021
BlackRock 298k $1.7M -1% Mar 2021
Caas Capital Management 223k $1.3M 100% Mar 2021

Setup an alert

Want to be notified whenever an investor makes a significant change to their holdings of Autolus Therapeutics Plc spon ads?

Laurion Capital Management 153k $876k 100% Mar 2021
Boothbay Fund Management 150k $859k 100% Mar 2021
BT Investment Management 122k $1.0M 141% Mar 2021
Marshall Wace 99k $568k 100% Mar 2021
Renaissance Technologies 82k $467k 1% Mar 2021
Two Sigma Investments 77k $442k 100% Mar 2021
Wells Fargo & Company 70k $402k 162% Mar 2021
Regency Capital Management 61k $350k 100% Mar 2021
Henry James International Management 54k $310k 100% Mar 2021
Citadel Advisors 42k $239k 119% Mar 2021
CalPERS 41k $233k -9% Mar 2021
New York State Common Retirement Fund 34k $197k 0% Mar 2021
Nomura Holdings 30k $165k 100% Mar 2021
Bank of America Corporation 27k $152k 4616% Mar 2021
Cubist Systematic Strategies 26k $149k 100% Mar 2021
State Street Corporation 23k $129k 0% Mar 2021
Jump Financial 20k $113k 100% Mar 2021
UBS Group 19k $107k 238% Mar 2021
Geode Capital Management 16k $90k 0% Mar 2021
Weiss Multi-strategy Advisers 14k $80k -25% Mar 2021
Two Sigma Advisers 14k $80k 100% Mar 2021
Natixis 13k $72k 100% Mar 2021
Goldman Sachs Group 12k $66k -20% Mar 2021
Legal & General Group 11k $63k 0% Mar 2021
Hrt Financial 11k $62k 100% Mar 2021
Victory Capital Management 6.0k $34k -92% Mar 2021
Advisor Group Holdings 5.9k $34k 15% Mar 2021
Tower Research Capital 3.1k $17k 91% Mar 2021
Lindbrook Capital 3.0k $17k 394% Mar 2021
Sowell Financial Services 1.5k $8.0k 100% Mar 2021
Proequities 1.0k $6.0k 0% Mar 2021
Total Clarity Wealth Management 1.0k $6.0k 100% Mar 2021
Penserra Capital Management 770.00 $4.0k -3% Mar 2021
Us Bancorp 669.00 $6.3k 24% Mar 2021
Citigroup 651.00 $4.0k -36% Mar 2021
Royal Bank of Canada 276.00 $2.0k 142% Mar 2021
Exane Derivatives 180.00 $1.0k 0% Mar 2021
Bank Of Montreal 145.00 $1.0k 100% Mar 2021
Barclays 90.00 $999.999000 -39% Mar 2021
Daiwa Securities Group 74.00 $0 0% Mar 2021

Who sold out of Autolus Therapeutics Plc spon ads?

Fund or Company Name Date Sold Shares Held Valued At
Franklin Resources Dec 2020 571k $5.1M
Eversept Partners Dec 2020 155k $1.4M
Morgan Stanley Dec 2020 129k $0
MPM Oncology Impact Management Dec 2020 40k $355k
Burrage Capital Management Dec 2020 15k $134k
Parallel Advisors Dec 2020 229.00 $2.0k